N. Kofi Addo

Clinical Quality Control Oversight Risk Manager @Shionogi Inc. (U.S.)

Philadelphia, PA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Nov 2023 — Present

Clinical Quality Control Oversight Risk Manager @Shionogi Inc. (U.S.)

View department →

Florham Park, NJ, US

Leading risk assessment and mitigation strategies for multiphase global studies across therapeutic areas such as neurology, hepatic and renal impairment, and rare diseases, including development and maintenance of Risk Assessment Categorization Tools (RACT) and integrated quality risk management plans.• Overseeing centralized monitoring data reviews to ensure timely identification of critical findings and facilitating cross-functional SMEs collaboration to validate risk signals and implement corrective actions.• Implementing and optimizing centralized monitoring plans to detect risks to critical data and processes, protocol deviations, and site performance issues using KRIs and QTLs.• Collaborating with Clinical Quality Oversight to align monitoring deliverables, study plans, and training materials with Shionogi SOPs and RBQM principles.• Advising CRO teams and internal stakeholders on QCO-risk expectations, centralized monitoring processes, and risk-based oversight strategies to ensure study success.

EDUCATION

2013 — 2017

Rutgers University

Bachelor of Science (B.S.) Public Health, Public Health

2017 — 2019

Boston University School of Public Health

Master of Public Health

SKILLS

Data AnalysisPhotographyClinical TrialsTeachingTime ManagementMicrosoft PowerpointCommunity OutreachResearchEvent PlanningMicrosoft OfficeSalesLeadershipTeamworkSciencePublic SpeakingMicrosoft ExcelPowerpointStatisticsWritingStrategic CommunicationsPcrStaff DevelopmentStudent AffairsStudent LeadershipSocial MediaSpssNeeds AssessmentCustomer ServiceLiterature ReviewsHigher EducationMicrosoft WordTeam LeadershipSocial Networking

ABOUT N. KOFI ADDO

I specialize in clinical risk oversight for multiphase global clinical trials, ensuring compliance with ICH E6(R2/R3) and GCP principles through risk-based quality management (RBQM) and centralized monitoring. I use data-driven insights, including KRIs and QTLs, to proactively identify and mitigate risks, safeguard patient safety, and maintain trial integrity. My experience spans therapeutic areas such as CNS, neurology, hepatic and renal impairment, and rare diseases, where I deliver tailored risk management strategies for high-complexity protocols.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.